Strategic Wealth Partners, Ltd. Astrazeneca PLC Transaction History
Strategic Wealth Partners, Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of Strategic Wealth Partners, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 158,945 shares of AZN stock, worth $11.7 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
158,945
Previous 97,686
62.71%
Holding current value
$11.7 Million
Previous $7.61 Million
36.83%
% of portfolio
1.01%
Previous 0.8%
Shares
20 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...